Industry Presentations

Acute Lymphoblastic Leukemia (ALL)


  • NON

    A Treatment Option for Adults with Relapsed or Refractory B-Cell Precursor ALL

    Speakers:Susan M. O’Brien, MD

    Duration: 30 minutes

    Presented on: November 3, 2017

    *This session is not eligible for AMA PRA Category 1 CreditsTM


  • Susan M. O’Brien, MD

    Susan M. O’Brien, MD

    Susan M. O’Brien, MD

    Dr. Susan O'Brien is a UC Irvine hematology oncologist who specializes in hematology and medical oncology. She oversees and coordinates clinical cancer research in medical oncology, radiation oncology, surgical oncology, and gynecologic oncology, across the entire UC Irvine Health enterprise.

    Her clinical expertise is in the diagnosis and treatment of leukemia, and she is actively involved in clinical trials as director of the UC Irvine Health Sue and Ralph Stern Center for Cancer Clinical Trials and Research.

    O’Brien earned her medical degree at the University of Medicine and Dentistry of New Jersey in Newark, where she also completed her residency in internal medicine, followed by a fellowship in hematology/oncology at University of Texas MD Anderson Cancer Center in Houston.